Financial

Amida Chosen for Inclusion in North Carolina’s Department of Health and Human Services Agreement to Advance AI and ML

Amida joins select vendor pool to design and implement best-in-class solutions for Medicaid WASHINGTON--(BUSINESS WIRE)--Amida Technology Solutions, Inc, (Amida) a…

1 month ago

Amida Chosen for Inclusion in North Carolina’s Department of Health and Human Services Agreement to Advance AI and ML

Amida joins select vendor pool to design and implement best-in-class solutions for Medicaid WASHINGTON--(BUSINESS WIRE)--Amida Technology Solutions, Inc, (Amida) a…

1 month ago

Evolent Announces Third Quarter 2025 Results

Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026.…

2 months ago

Pharmacovigilance Market to Reach $26.2 billion, Globally, by 2034 at 12.3% CAGR: Allied Market Research

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role…

2 months ago

Verseon’s Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences

One paper presented at IEEE International Conference on Future Machine Learning and Data Science 2025 covers Verseon's superior predictions of…

2 months ago

Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients

The milestone underscores Arkstone's leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding…

2 months ago

Nucleome Therapeutics founder Professor James Davies and Oxford University publish paper in prestigious journal Cell

Groundbreaking research using Nucleome MCC technology reveals complex structure of DNA inside living cells at base pair resolution for the…

2 months ago

Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Revenue growth of 113% driven by strong performance in molecular profiling services Raises 2025 revenue guidance to $720 to $730…

2 months ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 5, 2025…

2 months ago

From Whitening to AI Diagnostics: Robert Hayman, the Visionary Behind Zoom! Whitening, Leads Dentistry’s Next Global Breakthrough

REDMOND, Wash., Nov. 5, 2025 /PRNewswire/ -- Following the first FDA clearance for technology that measures internal mobility in teeth,…

2 months ago